Association of the TRAF1-C5 locus on chromosome 9 with juvenile idiopathic arthritis

Arthritis and Rheumatism

Volumn 58, Issue 7, 2008, Pages 2206-2207

  Behrens, Edward M ^a   Finkel, Terri H ^a   Bradfield, Jonathan P ^a   Kim, Cecilia E ^a   Linton, LaKenya ^a   Casalunovo, Tracy ^a   Frackelton, Edward C ^a   Santa, Erin ^a   Otieno, F George ^a   Glessner, Joseph T ^a   Chiavacci, Rosetta M ^a   Grant, Struan F A ^a   Hakonarson, Hakon ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; HLA DR ANTIGEN; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ARTICLE; C5 GENE; CHROMOSOME 9; ENTHESITIS; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MICROSATELLITE MARKER; PHENOTYPE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRAF1 GENE;

ARTHRITIS, JUVENILE RHEUMATOID; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 9; COMPLEMENT C5; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TNF RECEPTOR-ASSOCIATED FACTOR 1;

EID: 47249158540     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23603     Document Type: Article

References (7)

1. Hinks A, Barton A, John S, Bruce I, Hawkins C, Griffiths, CE, et al. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum 2005;52:1694-9.
2. Thompson SD, Moroldo MB, Guyer L, Ryan M, Tombragel EM, Shear ES, et al. A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage. Arthritis Rheum 2004;50:2920-30.
3. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N Engl J Med 2007;357:1199-209.
4. Moore TL. Immunopathogenesis of juvenile rheumatoid arthritis. Curr Opin Rheumatol 1999;11:377-83.
5. Lovell DJ, Reiff A, Jones OY, Schneider R, Nocton J, Stein LD, et al. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 2006;54:1987-94.
6. Wang Y, Kristan J, Hao L, Lenkoski CS, Shen Y, Matis LA. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J Immunol 2000;164:4340-7.
7. Wang Y, Rollins SA, Madri JA, Matis LA. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc Natl Acad Sci U S A 1995;92:8955-9.